Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 15 (1), R58
- https://doi.org/10.1186/cc10031
Abstract
To investigate the effects of G-CSF or GM-CSF therapy in non-neutropenic patients with sepsis.This publication has 56 references indexed in Scilit:
- Sepsis: Time has come to focus on the later stagesMedical Hypotheses, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Critical Care Medicine, 2007
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in ThailandClinical Infectious Diseases, 2007
- Septic shockThe Lancet, 2005
- Perioperative Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Prevents Immunoinflammatory Dysfunction Associated With Major SurgeryAnnals of Surgery, 2004
- The Pathophysiology and Treatment of SepsisThe New England Journal of Medicine, 2003
- EFFECT OF RECOMBINANT HUMAN GRANULOCYTE COLONY- STIMULATING FACTOR ON HEMODYNAMIC AND CYTOKINE RESPONSE IN A PORCINE MODEL OF PSEUDOMONAS SEPSISShock, 1995
- Effects of Granulocyte Colony Stimulating Factor and Monobactam Antibiotics (Aztreonam) on Neutrophil Functions in SepsisClinical Immunology and Immunopathology, 1993